Literature DB >> 18651816

Resistance profiles in surgical-site infection.

Andreas M Lenz1, Mark Fairweather, William G Cheadle.   

Abstract

Surgical-site infections (SSIs) remain a common complication, affecting some 5% of patients undergoing surgical procedures and can sometimes present a major challenge after surgery with life-threatening septic illness. The appearance of organisms that are often resistant to common antibiotic treatment is of great concern. Staphylococcus aureus is the organism most commonly recovered from infected surgical wounds, and usually contaminates wounds from the patients own skin. SSIs occur despite appropriate skin disinfection, sterilization of instruments, use of gown and gloves, appropriate sterile technique and prophylactic antimicrobials. In fact, it is difficult to maintain a sterile field over time, and most wounds become contaminated throughout the course of surgery. Methicillin-resistant S. aureus (MRSA) first arose in the hospital setting, but have more recently evolved in the community. Such community-acquired MRSA are genetically different and seem to be even more virulent owing to genes that encode virulence factors, such as staphylococcal cassette chromosome mec type IV and Panton-Valentine leukocidin. The purpose of this review is to summarize characteristics of frequently isolated bacterial strains from SSIs. The focus will be on Gram-positive organisms because of their increasing prevalence in SSIs and their high potential to develop resistance against several antibiotic agents, including vancomycin.

Entities:  

Mesh:

Year:  2008        PMID: 18651816     DOI: 10.2217/17460913.3.4.453

Source DB:  PubMed          Journal:  Future Microbiol        ISSN: 1746-0913            Impact factor:   3.165


  2 in total

1.  Preventing Surgical Site Infections Using a Natural, Biodegradable, Antibacterial Coating on Surgical Sutures.

Authors:  Jochen Reinbold; Ann-Kristin Uhde; Ingrid Müller; Tobias Weindl; Jürgen Geis-Gerstorfer; Christian Schlensak; Hans-Peter Wendel; Stefanie Krajewski
Journal:  Molecules       Date:  2017-09-19       Impact factor: 4.411

2.  Safety, tolerability, and immunogenicity of a novel 4-antigen Staphylococcus aureus vaccine (SA4Ag) in healthy Japanese adults.

Authors:  Megumi Inoue; Takuma Yonemura; James Baber; Yasuko Shoji; Masakazu Aizawa; David Cooper; Joseph Eiden; William C Gruber; Kathrin U Jansen; Annaliesa S Anderson; Alejandra Gurtman
Journal:  Hum Vaccin Immunother       Date:  2018-08-17       Impact factor: 3.452

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.